Place of procalcitonin in the diagnosis of post-surgical complications in heart surgery;Place de la procalcitonine dans le diagnostic des complications post-opératoires en chirurgie cardiaque

Feuillets de Biologie

Volumn 47, Issue 271, 2006, Pages 25-28

  Aouni, Z ^a   Jebali, A ^a   Mazigh, C ^a   Nsiri, B ^a   Ferjani, M ^a   Machghoul, S ^a  

^a MILITARY HOSPITAL OF TUNIS   (Tunisia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33746861934     PISSN: 04282779     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Aouifi A, Piriou V, Blanc P, Bouvier H, Bastien O, Chiari P, et al. Effect of cardiopulmonary bypass on serum procalcitonin and C-reactive protein concentrations. Br J Anaesth 1999 ; 83 : 602-7.
2. Aouifi A, Piriou V, Bastien O, Blanc P, Bouvier H, Evans R, et al. Usefulness of procalcitonin for diagnosis of infection in cardiac surgical patients. Crit Care Med 2000, 28 : 3171-6.
3. Boeken U, Feindt P, Petzold T, Klein M, Micek M, Seyfert UT et al. Diagnostic value of procalcitonin : the influence of cardiopulmonary bypass, aprotinin, SIRS and sepsis. Thorac Cardiovasc Surg 1998 ; 46 : 348-51.
4. Ferrière F. Intérêt de la procalcitonine, nouveau marqueur de l'infection bactérienne. Ann Biol Clin 2000 ; 58 : 49-59.
5. Guven H, Altintop L, Baydin A, Esen S, Aygun D, Hoklek M, Doganay Z, Bek Y. Diagnostic value of procalcitonine levels as an early indicator of sepsis. Am J Emerg Med 2002 ; 3 : 202-206.
6. Harbarth S, Holeckova K, Froidevaux C, Pittet D, Ricou B, Grau G E, Vadas L, Pugin J. Diagnostic value of procalcitonine, interleukin-6, and interleukin-8 in critically ill patients admitted with suspected sepsis. Am J Respir Crit Care Med 2001 ; 164 : 396-402.
7. Haberer J P. La procalcitonine, marqueur des infections sévères et du sepsis chez les patients hospitalisés en réanimation. Cah Anesthesiol 2000 ; 48 (3) : 209-210.
8. Hill GE, Whitten CW, Landers D. The influence of cardiopulmonary bypass on cytokines and cell-cell communication. J Cardiothorac Vasc Anesth 1997 ; 11 : 367-75.
9. Kerbaul F, Guidon C, Lejeune P J et al. Hyperprocalcitonemia Is Related to Noninfectious Postoperative Severe Systemic Inflammatory Response Syndrome Associated With Cardiovascular Dysfunction After Coronary Artery Bypass Graft Surgery. J Cardiothorac Anesth 2002 ; 16 : 47-53.
10. Lecharny J-B, Khater D, Bronchard R, et al. Hyperprocalcitonemia in patients with perioperative myocardial infarction after cardiac surgery. Crit Care Med 2001 ; 29 : 323-25.
11. Meisner M, Rauschmayer C, Schmidt J, Feyrer R, Cesnjevar R, Bredle D, Tschaikowsky K. Early increase of procalcitonin after cardiovascular surgery in patients with postoperative complications. Intensive Care Med. 2002 ; 28 (8) : 1094-102.
12. Selberg O, Hecker H, Martin M, Klos A, Bautsch W, Kohl J. Discrimination of sepsis and systemic inflammatory response syndrome by determination of circulating plasma concentrations of procalcitonin, protein complement 3a, and interleukin-6. Crit Care Med 2000 ; 28 : 2793-8.
13. Tentaiilon A, Reignier J. Définition des états infectieux. Encycl Méd Chir (Elsevier, Paris), Anesthésie-Réanimation, 36-983-A-10, 1996, 4 p.
14. Venet C, Tardy B, Zéini F. Marqueurs biologiques de l'infection en réanimation chez l'adulte : place de la procalcitonine. Réanimation 2002 ; 11 : 1-16.
15. Wan S, Le Clerc JL, Vincent JL. Inflammatory response to cardiopulmonary bypass : mechanisms involved and possible therapeutic strategies. Chest 1997 ; 112 (3) : 676-692.
16. Xia ZY, Zhan LY, He YH, Liu XY. The effect of Shen-Fu on gastrointestinal tract injury and its potential mechanism during cardio-pulmonary bypass in patients undergoing cardiac surgery. Clin J Traumatol 2003 ; 6 (4) : 245-248.